Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 367379, 8 pages
http://dx.doi.org/10.1155/2015/367379
Research Article

Animal Study on Primary Dysmenorrhoea Treatment at Different Administration Times

1Tianjin State Key Laboratory of Modern Chinese Medicine, School of Traditional Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
2Research Center of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China

Received 25 September 2014; Revised 4 January 2015; Accepted 12 January 2015

Academic Editor: David Baxter

Copyright © 2015 Bao-Chan Pu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Proctor and C. Farquhar, “Diagnosis and management of dysmenorrhoea,” British Medical Journal, vol. 332, no. 7550, pp. 1134–1138, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. A. R. Davis and C. L. Westhoff, “Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives,” Journal of Pediatric and Adolescent Gynecology, vol. 14, no. 1, pp. 3–8, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. A. R. D. Davis and C. L. Westhoff, “Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives,” Journal of Pediatric and Adolescent Gynecology, vol. 14, no. 1, pp. 3–8, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. Ö. Kaplan, M. Nazıroğlu, M. Güney, and M. Aykur, “Non-steroidal anti-inflammatory drug modulates oxidative stress and calcium ion levels in the neutrophils of patients with primary dysmenorrhea,” Journal of Reproductive Immunology, vol. 100, no. 2, pp. 87–92, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Y. Dawood, “Nonsteroidal anti-inflammatory drugs and changing attitudes toward dysmenorrhea,” The American Journal of Medicine, vol. 84, no. 5, pp. 23–29, 1988. View at Google Scholar · View at Scopus
  6. F. Cheng, H. Cheng, J. H. Cao et al., “Exploration of TCM syndrome distribution characteristics of primary dysmenorrhea,” Journal of Chinese Medicine, vol. 28, no. 183, pp. 1194–1196, 2013. View at Google Scholar
  7. R. F. Peng and D. Yi, “Study progress on pharmacodynamics of DangGui and its active ingredients,” Western Journal of Traditional Chinese Medicine, vol. 25, no. 9, pp. 125–128, 2012. View at Google Scholar
  8. Y. Q. Hua, S. L. Su, J. A. Duan, Q. J. Wang, Y. Lu, and L. Chen, “Danggui-Shaoyao-San, a traditional Chinese prescription, suppresses PGF2α production in endometrial epithelial cells by inhibiting COX-2 expression and activity,” Phytomedicine, vol. 15, no. 12, pp. 1046–1052, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Q. Xi, Z. Ke, and Y. L. Rong, “Progress of Chuanxiong volatile oil,” Lishizhen Medicine and Materia Medica Research, vol. 18, no. 6, pp. 1508–1510, 2007. View at Google Scholar
  10. G. J. Yu and M. L. Ao, “Analysis of the pharmacological effects of motherwort,” Seek Medical and Ask the Medicine, vol. 10, no. 6, article 791, 2012. View at Google Scholar
  11. J. X. Lan, H. Hao, and L. Z. Chang, “Review in research of radix Paeoniae rubra,” Drug Evaluation Research, vol. 33, no. 6, pp. 233–236, 2010. View at Google Scholar
  12. L. Fang, X. B. Zhu, C. C. Zhu et al., “The study on the mechanism of JQF for the treatment of primary dysmenorrheal,” Chinese Traditional and Herbal Drugs, vol. 41, no. 4, pp. 615–617, 2010. View at Google Scholar
  13. L. Fang, X. B. Zhu, J. Yin et al., “Mechanisms of JQF prescription on experimental dysmenorrhea in rats,” Tianjin Journal of Traditional Chinese Medicine, vol. 27, no. 1, pp. 46–49, 2010. View at Google Scholar
  14. X. M. Sun, G. Y. Jiang, X. Y. Lai et al., “Study on active ingredients of JQF prescription for treating dysmenorrhea,” Journal of Tianjin University of Traditional Chinese Medicine, vol. 30, no. 4, pp. 220–224, 2011. View at Google Scholar
  15. L. Wei, M. L. Wang, and Z. X. Shen, “Introduces the current development of TCM internationalization,” The Asia-pacific Traditional Medicine, no. 12, pp. 24–26, 2006. View at Google Scholar
  16. Y. Chen, “On the development of TCM internationalization,” Journal of Traditional Chinese Medicine Management, vol. 20, no. 9, pp. 820–822, 2006. View at Google Scholar
  17. L. Jing, “Clinical observation of ‘Tongjing Decoction’ in periodically treating dysmenorrhea of cold-blood deficiency,” Shanghai Journal of Traditional Chinese Medicine, vol. 45, no. 1, pp. 57–59, 2011. View at Google Scholar
  18. X. Y. Li, “Clinical observation on the cycle treatment with TCM ofprimary dysmenorrhea,” Journal ofEmergency in Traditional Chinese Medicine, vol. 17, no. 8, pp. 1075–1078, 2008. View at Google Scholar
  19. R. Y. Gu, B. Q. Jing, Z. Y. Song et al., “Observation of efficacy on primary dysmenorrhea treated by periodic therapy of Chinese herbal medicine,” Journal of Sichuan of Traditional Chinese Medicine, vol. 30, no. 12, pp. 90–92, 2012. View at Google Scholar
  20. D. J. Li, J. Jun, C. L. Liu et al., “Effect of Zinitongjingning to qi stagnation and blood stasis type primary dysmenorrhea of serum sex hormone, prostaglandin and calcium, magnesium,” Clinical Journal of Traditional Chinese Medicine, vol. 24, no. 10, pp. 949–952, 2012. View at Google Scholar
  21. X. Q. Zhang, “Clinical observation on treating 81 cases of primary dysmenorrhea in TCM,” Clinical Journal of Chinese Medicine, vol. 5, no. 18, pp. 66–67, 2013. View at Google Scholar
  22. K. He, J. Liu, Q. Li et al., “Effects of Dan'e Fukang decocted extract on dysmenorrhea mice,” Pharmacology and Clinics of Chinese Materia Medica, vol. 28, no. 3, pp. 106–108, 2012. View at Google Scholar
  23. L. B. Zhang, X. Q. Yan, J. A. Duan et al., “Influence of the different extracts of Artemisiae argyi on primary dysmenorrheal model in mice,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 18, no. 12, pp. 205–208, 2012. View at Google Scholar
  24. L. F. Li, L. J. Xie, and G. F. Li, “Effects of Fufang Xiaojingtong Capsule on dysmenorrhea induced by oxytocin in rats,” Chinese Traditional Patent Medicine, vol. 31, no. 3, pp. 363–367, 2009. View at Google Scholar
  25. N. Dai, L. Fang, Y.-B. Li, Y.-M. Wang, J. Yin, and B.-C. Pu, “Effect of Jingqian Zhitong Fang on serum sex hormone levels in women with primary dysmenorrhea,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 876431, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Fang, X. Y. Lai, Y. J. Zhang et al., “The clinical observation of JQF for the treatment of primary dysmenorrheal,” Chinese Archives of Traditional Chinese Medicine, vol. 29, no. 11, pp. 2480–2481, 2011. View at Google Scholar
  27. L. Fang, G. Y. Jiang, N. Dai et al., “Clinical observation on therapeutic effect of administration of drug in treating primary dysmenorrhea during luteal regression stage,” Journal of Tianjin University of Traditional Chinese Medicine, vol. 31, no. 2, pp. 77–79, 2012. View at Google Scholar
  28. J. Li, X. C. Li, and Y. X. Wu, “Comparative study of the three methods of confirming estrous cycle of mice,” Laboratory Animal Science, vol. 24, no. 3, pp. 62–65, 2007. View at Google Scholar
  29. H.-Y. Sun, Y.-X. Cao, J. Liu, J.-W. Gao, and M. Ma, “The establishment of the dysmenorrhea model in mice,” Chinese Pharmacological Bulletin, vol. 18, no. 2, pp. 233–236, 2002. View at Google Scholar · View at Scopus
  30. C. Schmauss and T. L. Yaksh, “In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta, and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat,” Journal of Pharmacology and Experimental Therapeutics, vol. 228, no. 1, pp. 1–12, 1984. View at Google Scholar · View at Scopus
  31. Q. Chen, Research Methods in Pharmacology of Chinese Materia Medica, People's Medical Publishing, Beijing, China, 2011.
  32. B. Ji, L.-F. Zhang, J. Zhu et al., “On building the dysmenorrhea model and assessment methods,” Chinese Pharmacological Bulletin, vol. 24, no. 6, pp. 711–714, 2008. View at Google Scholar · View at Scopus
  33. Y. J. Feng, Obstetricsand Gynecology, People's Medical Publishing House, Beijing, China, 2010.
  34. X. Y. Shi, Modern Medical Laboratory Animal Science, People's Military Medical Press, Beijing, China, 1999.
  35. M. A. Lumsden, R. W. Kelly, and D. T. Baird, “Primary dysmenorrhoea: the importance of both prostaglandins E2 and F2α,” British Journal of Obstetrics and Gynaecology, vol. 90, no. 12, pp. 1135–1140, 1983. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Nazar and K. Usmanghani, “Clinical evaluation to assess the safety and efficacy of coded herbal medicine ‘Dysmo-off’ versus allopathic medicine ‘Diclofenac Sodium’ for the treatment of primary dysmenorrhea,” Journal of Herbal Pharmacotherapy, vol. 6, no. 1, pp. 21–39, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. A. M. Powell, W. Y. Chan, P. Alvin, and I. F. Litt, “Menstrual-PGF2α, PGE2 and TXA2 in normal and dysmenorrheic women and their temporal relationship to dysmenorrhea,” Prostaglandins, vol. 29, no. 2, pp. 273–289, 1985. View at Google Scholar · View at Scopus
  38. R. A. Moya, C. F. Moisa, F. Morales, H. Wynter, A. Ali, and E. Narancio, “Transdermal glyceryl trinitrate in the management of primary dysmenorrhea,” International Journal of Gynecology and Obstetrics, vol. 69, no. 2, pp. 113–118, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. C.-H. Liao, C.-T. Ho, and J.-K. Lin, “Effects of garcinol on free radical generation and NO production in embryonic rat cortical neurons and astrocytes,” Biochemical and Biophysical Research Communications, vol. 329, no. 4, pp. 1306–1314, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Fenakel and S. Lurie, “The use of calcium channel blockers in obstetrics and gynecology; a review,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 37, no. 3, pp. 199–203, 1990. View at Publisher · View at Google Scholar · View at Scopus